Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data

Sang Gune K. Yoo*, Grace S. Chung, Bahendeka K. Silver, Abla M. Sibai , Albertino Damasceno , Farshad Farzadfar, Peter Rohloff, Corine Houehanou, Bolormaa Norov, Khem B. Karki, Mohammadreza Azangou-Khyavy, Maja E. Marcus, Krishna K. Aryal, Luisa C. C. Brant, Michaela Theilmann, Renata Cifkova, Nuno Lunet, Mongal S. Gurung, Joseph Kibachio Mwangi, Joao MartinsRosa Haghshenas, Lela Sturua, Sebastian Vollmer, Till Bärnighausen, Rifat Atun, Jeremy B. Sussman, Kavita Singh, Sahar Saeedi Moghaddam, David Guwatudde, Pascal Geldsetzer, Jennifer Manne-Goehler, Mark D. Huffman, Justine I. Davies, David Flood

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

62 Downloads (Pure)
Original languageEnglish
Article number44
Number of pages6
JournalGlobal Heart
Volume19
Issue number1
DOIs
Publication statusPublished - 3 May 2024

Keywords

  • cardiovascular disease
  • prevention
  • aspirin
  • Non-communicable disease

Cite this